MY Jeon, BK Kim, JS Lee, HW Lee… - Clinical and …, 2020 - pmc.ncbi.nlm.nih.gov
Background/Aims The immune-tolerant (IT) phase of chronic hepatitis B (CHB) patients is not generally indicative of antiviral therapy (AVT). We assessed and compared the risk of …
HY Chon, HA Lee, SJ Suh, JI Lee… - Alimentary …, 2021 - Wiley Online Library
Summary Background The modified PAGE‐B (mPAGE‐B) and PAGE‐B models reliably predict the risk of developing chronic hepatitis B (CHB)‐related hepatocellular carcinoma …
HS Chun, JS Lee, HW Lee, BK Kim, JY Park… - Digestive diseases and …, 2022 - Springer
Background The association between chronic hepatitis B (CHB) and cardiovascular disease (CVD) remains unclear. We investigated the prevalence and risk factors of CVD in patients …
MRF Nurkamal, V Indriani, IM Harini - Mandala Of Health, 2021 - jos.unsoed.ac.id
Sirosis hepatis dianggap sebagai kondisi sebelum terjadinya karsinoma hepatoseluler. Sirosis hepatis dan karsinoma hepatoseluler perlu dideteksi lebih awal dengan …